Red X iconGreen tick iconYellow tick icon

Contact Details

Email
aline.boer@otago.ac.nz
Position
Research Fellow
Research summary
Research into the central role of glucose-dependent insulinotropic polypeptide (GIP) in the regulation of body weight
Memberships
Publicity and Events Committee

Publications

Pretz, D., Heyward, P. M., Krebs, J., Gruchot, J., Barter, C., Silcock, P., Downes, N., Rizwan, M. Z., Boucsein, A., Bender, J., Burgess, E. J., Boer, G. A., Keerthisinghe, P., Perry, N. B., & Tups, A. (2023). A dahlia flower extract has anti-diabetic properties by improving insulin function in the brain. Life Metabolism, 2(4), load026. doi: 10.1093/lifemeta/load026

Boer, G. A., Hay, D. L., & Tups, A. (2022). Obesity pharmacotherapy: Incretin action in the central nervous system [Review]. Trends in Pharmacological Sciences, 44(1), 50-63. doi: 10.1016/j.tips.2022.11.001

Gabe, M. B. N., Skov-Jeppesen, K., Gasbjerg, L. S., Schiellerup, S. P., Martinussen, C., Gadgaard, S., Boer, G. A., … Rosenkilde, M. M. (2022). GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment. Pharmacological Research, 176, 106058. doi: 10.1016/j.phrs.2022.106058

Gadgaard, S., van der Velden, W. J. C., Schiellerup, S. P., Hunt, J. E., Gabe, M. B. N., Windeløv, J. A., Boer, G. A., … Rosenkilde, M. M. (2022). Novel agonist- and antagonist-based radioligands for the GLP-2 receptor: Useful tools for studies of basic GLP-2R pharmacology. British Journal of Pharmacology, 179, 1998-2015. doi: 10.1111/bph.15766

Boer, G. A., Hartmann, B., & Holst, J. J. (2021). Pharmacokinetics of exogenous GIP(1-42) in C57Bl/6 mice: Extremely rapid degradation but marked variation between available assays. Peptides, 136, 170457. doi: 10.1016/j.peptides.2020.170457

Pretz, D., Heyward, P. M., Krebs, J., Gruchot, J., Barter, C., Silcock, P., Downes, N., Rizwan, M. Z., Boucsein, A., Bender, J., Burgess, E. J., Boer, G. A., Keerthisinghe, P., Perry, N. B., & Tups, A. (2023). A dahlia flower extract has anti-diabetic properties by improving insulin function in the brain. Life Metabolism, 2(4), load026. doi: 10.1093/lifemeta/load026

Journal - Research Article

Boer, G. A., Hay, D. L., & Tups, A. (2022). Obesity pharmacotherapy: Incretin action in the central nervous system [Review]. Trends in Pharmacological Sciences, 44(1), 50-63. doi: 10.1016/j.tips.2022.11.001

Journal - Research Article

Gabe, M. B. N., Skov-Jeppesen, K., Gasbjerg, L. S., Schiellerup, S. P., Martinussen, C., Gadgaard, S., Boer, G. A., … Rosenkilde, M. M. (2022). GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment. Pharmacological Research, 176, 106058. doi: 10.1016/j.phrs.2022.106058

Journal - Research Article

Gadgaard, S., van der Velden, W. J. C., Schiellerup, S. P., Hunt, J. E., Gabe, M. B. N., Windeløv, J. A., Boer, G. A., … Rosenkilde, M. M. (2022). Novel agonist- and antagonist-based radioligands for the GLP-2 receptor: Useful tools for studies of basic GLP-2R pharmacology. British Journal of Pharmacology, 179, 1998-2015. doi: 10.1111/bph.15766

Journal - Research Article

Boer, G. A., Hartmann, B., & Holst, J. J. (2021). Pharmacokinetics of exogenous GIP(1-42) in C57Bl/6 mice: Extremely rapid degradation but marked variation between available assays. Peptides, 136, 170457. doi: 10.1016/j.peptides.2020.170457

Journal - Research Article

Boer, G. A., Keenan, S. N., Miotto, P. M., Holst, J. J., & Watt, M. J. (2021). GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism. American Journal of Physiology: Heart & Circulatory Physiology, 320(4), E835-E845. doi: 10.1152/AJPENDO.00646.2020

Journal - Research Article

Lubberding, A. F., Zhang, J., Lundh, M., Nielsen, T. S., Søndergaard, M. S., Villadsen, M., … Boer, G. A., … Torekov, S. S. (2021). Age-dependent transition from islet insulin hypersecretion to hyposecretion in mice with the long QT-syndrome loss-of-function mutation Kcnq1-A340V. Scientific Reports, 11(1), 12253. doi: 10.1038/s41598-021-90452-8

Journal - Research Article

Boer, G. A., & Holst, J. J. (2020). Incretin hormones and type 2 diabetes: Mechanistic insights and therapeutic approaches. Biology, 9(12), 473. doi: 10.3390/biology9120473

Journal - Research Article

Gobron, B., Bouvard, B., Vyavahare, S., Blom, L. V. V., Pedersen, K. K., Windeløv, J. A., Boer, G. A., … Mabilleau, G. (2020). Enteroendocrine K cells exert complementary effects to control bone quality and mass in mice. Journal of Bone & Mineral Research, 35(7), 1363-1374. doi: 10.1002/jbmr.4004

Journal - Research Article

Holst, J. J., Windeløv, J. A., Boer, G. A., Pedersen, J., Svendsen, B., Christensen, M., … Nissen, A. (2016). Searching for the physiological role of glucose-dependent insulinotropic polypeptide. Journal of Diabetes Investigation, 7(Suppl. 1), 8-12. doi: 10.1111/jdi.12488

Journal - Research Other

Back to top